Hyaluronic acid (HA) possesses unique viscoelastic properties and low immunogenicity, making it suitable for various biomedical purposes such as viscosupplementation in osteoarthritis treatment, assistance in eye surgery, and wound regeneration. The need for its quantification in human biofluids is crucial in clinical studies. This research work presents a novel approach using paper-based and parafilm-based photochemical techniques, employing triangular silver nanoprisms (TA-AgNPrs) as optical nanoprobes for HA detection in human biofluids. The interaction between HA and TA-AgNPrs leads to a notable change in the absorption spectrum, facilitating rapid and reliable measurement with a detection limit of less than 0.5 μM to 30 mM. The developed colorimetric setups, along with the single-drop parafilm colorimetric substrate, enable fast and HA analysis. This research marks the maiden use of TA-AgNPrs for direct, rapid and sensitive HA detection in real samples, without the need for sample pre-preparation. The use of a digital image analysis strategy enhances the simplicity, affordability, and portability of this sensor, presenting promising potential for monitoring HA levels. This new technique is poised to enable early diagnosis of diseases associated with abnormal HA levels in human biofluids, thanks to its high sensitivity and selectivity in detecting HA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11299643 | PMC |
http://dx.doi.org/10.1039/d4ra05396f | DOI Listing |
Biosensors (Basel)
November 2024
Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Transactive response DNA-binding protein of 43 kDa (TDP-43) is a major component of pathological inclusions in various neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The detection of TDP-43 in biofluids is crucial for the development of diagnostic and prognostic indicators of disease and therapeutic development for TDP-43-related proteinopathies. Despite its potential as a biomarker for numerous neurological disorders, the lack of a sensitive and reproducible TDP-43 assay hinders progress in TDP-43-based therapy development, underscoring the need for an effective and standardized method for accurate quantification.
View Article and Find Full Text PDFFront Neurosci
December 2024
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Background: Extracellular vesicles are easily accessible in various biofluids and allow the assessment of disease-related changes in the proteome. This has made them a promising target for biomarker studies, especially in the field of neurodegeneration where access to diseased tissue is very limited. Genetic variants in the LRRK2 gene have been linked to both familial and sporadic forms of Parkinson's disease.
View Article and Find Full Text PDFCurr Neurol Neurosci Rep
December 2024
The NABI institute, Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Purpose Of Review: Early brain injury (EBI) after aneurysmal subarachnoid hemorrhage (SAH) is the most influential clinical determinant of outcomes. Despite significant advances in understanding of the pathophysiology of EBI, currently no treatments to target EBI have been developed. This review summarizes recent advances in EBI research over the past five years with a focus on potential therapeutic targets.
View Article and Find Full Text PDFParkinsonism Relat Disord
December 2024
Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway. Electronic address:
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disease, and biomarkers are needed to enhance earlier detection and monitoring. Alpha-synuclein, phosphorylated at serine 129 (pS129-α-syn), is the predominant form of α-syn found in Lewy bodies implicating an involvement in disease pathology. This review aims to systematically evaluate the evidence for pS129-α-syn detection in human biofluid samples of PD utilizing ELISA-based protein detection methods.
View Article and Find Full Text PDFBMJ Open Ophthalmol
December 2024
Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Objective: Age-related macular degeneration (AMD) is one of the leading causes of irreversible visual impairment and blindness in the elderly. As AMD is a multifactorial disease, it is critical to explore useful biomarkers and pathological pathways underlying it. The purpose of this study is to summarise current metabolic profiles and further identify potential metabolic biomarkers and therapeutic targets in AMD, which could facilitate clinical diagnosis and treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!